JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Love2

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Featured Articles, JDD Re:View, Latest News | No Comments
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Journal of Drugs in Dermatology JDD Article about Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

| Featured Articles, Latest News, Skin of Color | No Comments
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Journal of Drugs in Dermatology JDD Article about Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. Image shows thumb and nail or patient.

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

| Case Reports, Featured Articles, Latest News | No Comments
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…